IDEAS home Printed from https://ideas.repec.org/a/taf/recjxx/v14y2018i2-3p278-304.html
   My bibliography  Save this article

Lower drug prices can improve innovation

Author

Listed:
  • Marcel Canoy
  • Jan Tichem

Abstract

An often made claim is that high drug prices are necessary for innovation. We qualify the innovation claim. Drug prices can be too high when the price exceeds the value of the drug to society. Such prices lead to investment distortions. We propose a benchmark for identifying these cases in practice. Using the Netherlands as an example, we show that when innovation incentives are distorted. In these instances high prices crowd out other health investments and distort innovation. We subsequently discuss how competition law can be applied in this area. We conclude that in the case that a country pays more for a drug under patent protection than the proper willingness to pay, competition authorities can use this feature not only to counteract the argument that such prices are needed for innovation but also as an additional way to operationalize the United Brands test for excessive prices.

Suggested Citation

  • Marcel Canoy & Jan Tichem, 2018. "Lower drug prices can improve innovation," European Competition Journal, Taylor & Francis Journals, vol. 14(2-3), pages 278-304, September.
  • Handle: RePEc:taf:recjxx:v:14:y:2018:i:2-3:p:278-304
    DOI: 10.1080/17441056.2018.1512231
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1080/17441056.2018.1512231
    Download Restriction: Access to full text is restricted to subscribers.

    File URL: https://libkey.io/10.1080/17441056.2018.1512231?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:taf:recjxx:v:14:y:2018:i:2-3:p:278-304. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Chris Longhurst (email available below). General contact details of provider: http://www.tandfonline.com/recj .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.